Want to join the conversation?
$ANTM's revenue from Commercial and Specialty Business for 4Q15 fell by 3.3% to $9.40Bil from last year, while that from Government Business grew 17.4% to $10.61Bil. Overall, the 6.6% growth in total operating revenue reflected premium rises to cover overall cost trends and higher enrollment in the Medicaid and Commercial self-funded businesses.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.